Cue Biopharma, Inc.

What is a Form D filing?

A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Filing snapshot

Cue Biopharma, Inc. (based in MA) filed SEC Form D on July 22, 2026, disclosing a $50.0M offering of securities under Rule 506(b) of Regulation D. FormDFlow has tagged the issuer's sector as Biotech. This page reflects the public filing as recorded in SEC EDGAR; see the source document for the complete disclosure.

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Filing history

Cue Biopharma, Inc. has filed 2 Form D filings totaling $80.0M that FormDFlow has indexed.

• May 14, 2026Reg D 506(b)$30.0M

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.